PDL BioPharma, Inc. (PDLI) Misses Q2 EPS by 1c
Tweet Send to a FriendGet Alerts PDLI Hot Sheet
Price: $8.22 +0.49%
Revenue Growth %: -7.0%
Financial Fact:
Operating income: 84.66M
Today's EPS Names:
LBIX, ESEA, ISS, More
Revenue Growth %: -7.0%
Financial Fact:
Operating income: 84.66M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade PDLI Now!
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q2 adjusted EPS of $0.39, $0.01 worse than the analyst estimate of $0.40. Revenue for the quarter came in at $122.1 million versus the consensus estimate of $123.25 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Autodesk, Inc. (ADSK) Misses Q1 EPS by 3c, Offers Guidance
- ReneSola Ltd. (SOL) Posts Q1 Loss of 45c/ADS; Guides Q2, FY13 Shipments
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
